Neurology

FDA Clears Novel 'Recharge-Free' Device for Chronic Pain

Abbott’s Proclaim XR platform utilizes the company’s low energy BurstDR stimulation waveform to provide effective pain relief without the hassle of recharging for up to 10 years.
FDA Approvals

Source link

Related posts

Teaching NeuroImages: Unilateral focal segmental hyperhidrosis from spinal tumor progression

Newsemia

clinical neurology; +250 new citations

Newsemia

Clinical Reasoning: An unusual lung mass causing focal weakness

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy